Ophthalmology Case Reports

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Perspective - Ophthalmology Case Reports (2025) Volume 9, Issue 2

Corneal Therapies: Advancements and Treatments for Vision Restoration

Rasmus Sun*

Department of Electrical and Computer Engineering, Aarhus University, Denmark

*Corresponding Author:
Rasmus Sun
Department of Electrical and Computer Engineering, Aarhus University, Denmark
E-mail: rasun@ece.au.dk

Received:01-Apr-2025,Manuscript No.OER-25-164477; Editor assigned:02-Apr-2025, PreQC No.OER-25-164477; Reviewed:10-Apr-2025,QC No.OER-25-164477; Revised:21-Apr-2025,Manuscript No.OER-25-164477(R); Published: 30-Apr-2025, DOI:10.35841/ 10.35841/oer-9.2.266

Citation: Sun R. Corneal Therapies: Advancements and Treatments for Vision Restoration. Ophthalmol Case Rep. 2025;9(2):266

Visit for more related articles at Ophthalmology Case Reports

Abstract

  

Introduction

The cornea, the transparent, dome-shaped surface of the eye, plays a crucial role in focusing light and enabling clear vision. When the cornea becomes damaged or diseased, it can lead to various vision problems, including blurred vision, sensitivity to light, and, in severe cases, blindness. Conditions such as keratoconus, corneal dystrophies, and corneal scarring can impair the cornea's structure and function, often requiring medical intervention to restore vision [1].

Over the years, significant advancements in corneal therapies have revolutionized the treatment of corneal diseases, providing new hope for patients with previously difficultto-treat conditions. From corneal transplants to innovative surgical techniques, a variety of therapies are now available to address corneal issues. This article explores the different corneal therapies currently in practice, the advancements in the field, and their potential to improve patient outcomes [2].

A progressive disorder where the cornea becomes thin and bulges outward into a cone shape. This can lead to distorted vision, sensitivity to light, and in some cases, scarring of the cornea. A group of inherited disorders that cause abnormal changes in the corneal tissue. These dystrophies can lead to clouding, vision impairment, and sometimes require corneal transplantation for correction. Scarring can result from trauma, infection (such as keratitis), or previous surgeries. Scarring can distort the cornea’s shape and impede light entry, causing visual disturbances. A genetic disorder that affects the corneal endothelial cells, leading to fluid buildup, corneal swelling, and clouding of the cornea [3].

Corneal transplantation, or keratoplasty, is a surgical procedure where a diseased or damaged cornea is replaced with a healthy donor cornea. There are different types of corneal transplants depending on the extent of the disease and which layers of the cornea are affected:A full-thickness transplant that replaces all layers of the cornea. It is used in cases where the cornea is severely damaged or scarred [4].

A partial-thickness transplant that replaces only certain layers of the cornea. Deep Anterior Lamellar Keratoplasty (DALK) and Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK) are examples of techniques that preserve some layers of the cornea. A newer technique that focuses on replacing only the damaged endothelial layer of the cornea, which is most commonly affected in conditions like Fuchs’ dystrophy. One common form of this is Descemet’s Membrane Endothelial Keratoplasty (DMEK), which provides faster recovery and fewer complications than full-thickness transplants [

Corneal cross-linking (CXL) is a treatment primarily used for keratoconus, a condition in which the cornea weakens and bulges into a cone shape. CXL strengthens the corneal tissue by using ultraviolet (UV) light and riboflavin (vitamin B2). This process creates chemical bonds between the collagen fibers in the cornea, increasing its rigidity and halting the progression of keratoconus [

In epi-off CXL, the corneal epithelium (the outer layer) is removed before applying riboflavin drops and exposing the cornea to UV light. In epion CXL, the epithelium is left intact, offering a less invasive option with shorter recovery times.CXL has been shown to slow or even stop the progression of keratoconus, providing an alternative to more invasive treatments such as corneal transplantation. It can also improve visual acuity in some patients and reduce the need for corrective lenses. Intacs are small, plastic ring segments that are surgically inserted into the cornea to improve its shape and flatten its curvature. This procedure is often used to treat keratoconus or to correct refractive errors such as myopia (nearsightedness) [

Stem cell therapy is a promising, cutting-edge treatment for corneal diseases. Corneal stem cell deficiency can occur when the stem cells in the limbus (the area where the cornea meets the sclera) are damaged, leading to chronic corneal scarring or blindness. Stem cell therapy involves transplanting healthy stem cells to regenerate the damaged corneal tissue. Stem cells are either harvested from the patient’s own eye (autologous stem cells) or from a donor, and then transplanted into the damaged area of the cornea. Over time, these stem cells regenerate the corneal surface and restore vision. This therapy offers the potential for healing corneal scarring or defects, especially in cases of chemical burns or severe trauma. It is still in the experimental stages but shows great promise in treating corneal stem cell deficiencies [

Research and development in corneal therapies are advancing rapidly, with new techniques and treatments emerging all the time. The integration of genetic therapies, bioprinting of corneal tissue, and further refinements in stem cell applications offer promising avenues for the future of corneal treatment. As these therapies evolve, they hold the potential to improve outcomes for patients with a wider range of corneal diseases, leading to better vision and quality of life. Moreover, the combination of advanced surgical techniques, biotechnology, and regenerative medicine may one day offer more personalized and effective treatment options for corneal conditions, reducing the need for invasive procedures like full corneal transplants. [

Conclusion

Advancements in corneal therapies are helping to restore and preserve vision for individuals suffering from a variety of corneal diseases. From corneal transplants and cross-linking treatments to stem cell therapy and laser procedures, there are now more options than ever for treating corneal conditions. As research continues, new and innovative therapies hold the promise of further improving the prognosis for patients with corneal disorders, ultimately leading to better visual outcomes and enhanced quality of life.

References

  1. Feizi S, Karimian F. Effect of higher order aberrations on contrast sensitivity function in myopic eyes. Jpn J Ophthalmol. 2009; 53(4):414-19.

    2. Indexed at, Google Scholar, Cross Ref

  2. Van de Velde M, Schepers R, Berends N, et al. Ten years of experience with accidental dural puncture and post-dural puncture headache in a tertiary obstetric anaesthesia department. Int J Obstet Anesth. 2008;17:329-35.

    3. Indexed at, Google Scholar, Cross Ref

  3. Ribatti D. Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma. Pharmaceuticals. 2010;3(4):1225-31.

    4. Indexed at, Google Scholar, Cross Ref

  4. Hamdi IM. Optical and topographic changes in keratoconus after implantation of Ferrara intracorneal ring segments. J Refract Surg. 2010;26(11):871-80.

    5. Indexed at, Google Scholar, Cross Ref

  5. logunde R, Aruthappu M, Arajah SK, et al. Surgical care in low and middle-income countries: Burden and barriers. Int J Surg. 2014;12(8):858-63.

    6. Indexed at, Google Scholar, Cross Ref

  6. Michali-Stolarska M, Bladowska J, Stolarski M, et al. Diagnostic imaging and clinical features of intracranial hypotension - review of literature. Pol J Radiol. 2017;82:842-49. 

    7. Indexed at, Google Scholar, Cross Ref

  7. Van de Velde M, Schepers R, Berends N, et al. Ten years of experience with accidental dural puncture and post-dural puncture headache in a tertiary obstetric anaesthesia department. Int J Obstet Anesth. 2008;17:329-35.

    8. Indexed at , Google Scholar, Cross Ref

  8. Chambers DJ, Bhatia K. Cranial nerve palsy following central neuraxial block in obstetrics - a review of the literature and analysis of 43 case reports. Int J Obstet Anesth. 2017;31:13-26.

    9. Indexed at, Google Scholar, Cross Ref

  9. Jung EH, Kim SJ, Lee JY, et al. The incidence and ethology of sixth cranial nerve palsy in Koreans: a 10-year nationwide cohort study. Sci Rep. 2019;9:18419.

    10. Indexed at, Google Scholar, Cross Ref

  10. Silvis SM, Lindgren E, Hiltunen S, et al. Postpartum period is a risk factor for cerebral venous thrombosis. Stroke. 2019;50:501-03.

    11. Indexed at, Google Scholar, Cross Ref

Get the App